Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,421.59
    -1,050.47 (-2.04%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Primary Care POC Diagnostics Market Poised for Expansion, Projected to Reach USD 26.17 Billion by 2030

Company Logo
Company Logo

Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Primary Care POC Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Lipid Testing, Drug Abuse Testing), By End-use (Pharmacy & Retail Clinics, Physician Office), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The launch of a comprehensive analysis on the global primary care point-of-care (POC) diagnostics market, showcasing promising growth with an expected reach of USD 26.17 billion by 2030, has been announced. This significant market expansion is anticipated to develop at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2023 to 2030.

Industry Insights Set the Stage for Innovation in Diagnostic Practices

In the rapidly evolving healthcare landscape, the emphasis has shifted towards more convenient and faster diagnostic solutions. This exhaustive research report highlights key trends, market drivers, and the role of primary care POC diagnostics in revolutionizing patient care methodologies.

ADVERTISEMENT

Infectious Disease Testing Leads Market Segmentation The infectious disease segment currently claims the largest market share, reflecting the high demand for expedient and accurate diagnosis amidst the rising prevalence of infectious conditions.

Lipid Testing Sees Uptick in Routine Out-Patient Practices

Clinics and physician offices are increasingly integrating lipid testing into routine examinations, which is projected to catalyze the growth of this product segment in the primary care POC diagnostics market.

End-Use Advancements Catalyze Growth

  • Cutting-edge research and innovative POC testing kits under development by biotech firms and research institutes are likely to augment the physician office end-use segment.

  • Simultaneously, government initiatives aiming to extend primary care facilities are projected to invigorate the non-practice clinics sector.

North America Sets the Benchmark for Primary Care POC Diagnostics North America, with its advanced healthcare infrastructure and heightened awareness, leads the charge in the adoption of POC diagnostics. The market in this region benefits from a variety of sophisticated POC diagnostic products and a growing inclination towards primary home healthcare services.

U.S. Market Shifts Towards Patient-Centric Home Care

The United States is currently witnessing a profound shift towards patient participation in home care and a rise in home-based diagnostic tests and monitoring devices. Furthermore, with an upsurge in the adoption of digital health records, telemedicine, and web-based monitoring solutions, the U.S. continues to spearhead the market's growth trajectory.

Key Report Takeaways

  1. Detailed analysis of the market segments experiencing rapid growth and their potential economic impact.

  2. Insightful exploration of trends shaping the future of primary care POC diagnostics.

  3. Evaluation of global and regional market dominions and their respective market shares.

The report's findings underscore a growing consensus within the healthcare community: point-of-care diagnostics in primary healthcare settings are crucial for enhancing patient outcomes and reducing overall healthcare expenditure. The integration of such diagnostic techniques aligns with the global shift towards more personalized, efficient, and patient-centric care.

Key Attributes

Report Attribute

Details

No. of Pages

192

Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$15.4 Billion

Forecasted Market Value (USD) by 2030

$26.17 Billion

Compound Annual Growth Rate

6.5%

Regions Covered

Global

Companies Mentioned

  • F Hoffmann-La Roche Ltd.

  • Danaher

  • Abbott

  • Siemens Healthineers

  • bioMerieux SA

  • Abaxis

  • QIAGEN

  • Johnson & Johnson Services, Inc.

  • Nova Biomedical

  • Instrumentation Laboratory

  • Trividia Health, Inc.

  • OraSure Technologies, Inc.

  • Quidel Corporation

  • Trinity Biotech

  • Sekisui Diagnostics

  • BD

Key Topics Covered

  1. Methodology and Scope

  2. Executive Summary

  3. Primary Care POC Diagnostics Market Variables, Trends & Scope

  4. Primary Care POC Diagnostics: Product Estimates & Trend Analysis

  5. Primary Care POC Diagnostics: End Use Estimates & Trend Analysis

  6. Primary Care POC Diagnostics Market: Regional Estimates & Trend Analysis

  7. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/hb8bym

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900